Earlier this year we learned that cancer, not heart disease it the leading cause of death in Americans under 85.
This article explores how agencies like the Amercian Cancer Society (ACS) have an eye for their own financial interests first. Why does the ACS reportedly put far greater financial emphasis on chemotherapy and radiation research than on life-saving prevention techniques? Why does the ACS appear to discredit physicians researching and practicing effective alternative cancer-fighting techniques? A closer look at the American Cancer Society reveals the agency’s ties to the cancer industry.
